Estrogenic endocrine disruptor exposure directly impacts erectile function

• Published in: Communications biology 2024-04, Vol.7 (1), p.403-16, Article 403
• Main Authors: Cripps, Samuel M., Marshall, Sarah A., Mattiske, Deidre M., Ingham, Rachel Y., Pask, Andrew J.
• Format: Article
• Language: English
• Subjects: 13; 13/106; 38; 631/136/1425; 64; 64/60; 692/163/2743/2730; 692/4025/2768/1575; Animals; Biomedical and Life Sciences; Contractility; Diethylstilbestrol; Endocrine disruptors; Endocrine Disruptors - toxicity; Erectile dysfunction; Erectile Dysfunction - chemically induced; Estrogen receptors; Genistein; Humans; Life Sciences; Male; Mice; Phytoestrogens; Quality of Life; Risk Factors; Testosterone; Xenoestrogens
• ISSN: 2399-3642; 2399-3642
• DOI: 10.1038/s42003-024-06048-1

Erectile dysfunction (ED) is an extremely prevalent condition which significantly impacts quality of life. The rapid increase of ED in recent decades suggests the existence of unidentified environmental risk factors contributing to this condition. Endocrine Disrupting Chemicals (EDCs) are one likely candidate, given that development and function of the erectile tissues are hormonally dependent. We use the estrogenic-EDC diethylstilbestrol (DES) to model how widespread estrogenic-EDC exposure may impact erectile function in humans. Here we show that male mice chronically exposed to DES exhibit abnormal contractility of the erectile tissue, indicative of ED. The treatment did not affect systemic testosterone production yet significantly increased estrogen receptor α ( Esr1 ) expression in the primary erectile tissue, suggesting EDCs directly impact erectile function. In response, we isolated the erectile tissue from mice and briefly incubated them with the estrogenic-EDCs DES or genistein (a phytoestrogen). These acute-direct exposures similarly caused a significant reduction in erectile tissue contractility, again indicative of ED. Overall, these findings demonstrate a direct link between estrogenic EDCs and erectile dysfunction and show that both chronic and acute estrogenic exposures are likely risk factors for this condition. Endocrine Disrupting Chemicals (EDCs) are a group of harmful environmental pollutants hypothesized to be drivers of multiple health disorders. In the current article, the estrogenic-EDC diethylstilbestrol (DES) is utilized to model how EDCs may impact erectile dysfunction, with DES causing abnormal erectile tissue contractility.